Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Bispecific T-cell engagers (BiTE): a review of tarlatamab in small cell lung cancer

2025Clinical & Translational OncologyJournal

10.1007/s12094-025-03980-4 Full text4 citations

Authors

10 authors across 10 institutions in 5 countries.

Ikponmwosa Jude OgieuhiFirst authorCorresponding
Victor Ajekiigbe
- Ladoke Akintola University of Technology (NG)
as printed: Victor Oluwatomiwa Ajekiigbe
Tolu Comfort Oladipo
- Afe Babalola University (NG)
Adedamola Solomon Oyenuga
- Lagos State Health Service Commission (NG)
Victor Olaiya
as printed: Victor Olamiposi Olaiya
Chidera Stanley Anthony
- University of Calabar (NG)
Chinonyelum Emmanuel Agbo
- University of Nigeria (NG)
Weam Salih Abdallah
- National University (SD)
Adewunmi Akingbola
Olanipekun Lanny NtukidemSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Lung Cancer Research Studieslevel 3 · 0.94
Monoclonal and Polyclonal Antibodies Researchlevel 3 · 0.02
Radiopharmaceutical Chemistry and Applicationslevel 3 · 0.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 24, 2026
2025 · Clinical & Translational Oncology · 4 citations
https://openalex.org/W4412046641

Bispecific T-cell engagers (BiTE): a review of tarlatamab in small cell lung cancer · Sankore